Anti-Human IL6R Therapeutic Antibody (Tocilizumab/Atlizumab)
Recombinant monoclonal antibody to Human IL6R. Tocilizumab (INN, or atlizumab is an immunosuppressive drug, mainly for the treatment of rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis, a severe form of RA in children. It is a humanized monoclonal antibody against the interleukin-6 receptor (IL-6R). Interleukin 6 (IL-6) is a cytokine that plays an important role in immune response and is implicated in the pathogenesis of many diseases, such as autoimmune diseases, multiple myeloma and prostate cancer.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-026 |
| Pricing | Inquiry |
| Host | Mouse |
| Target | IL6R |
| Species Reactivity | Human |
| Type | IgG1 - kappa |
| Applications | ELISA, FC, IP, FuncS, IF, Neut, ICC |
| Storage | Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples. |